618 related articles for article (PubMed ID: 32241904)
1. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents.
Wang X; Yang S; Li S; Zhao L; Hao Y; Qin J; Zhang L; Zhang C; Bian W; Zuo L; Gao X; Zhu B; Lei XG; Gu Z; Cui W; Xu X; Li Z; Zhu B; Li Y; Chen S; Guo H; Zhang H; Sun J; Zhang M; Hui Y; Zhang X; Liu X; Sun B; Wang L; Qiu Q; Zhang Y; Li X; Liu W; Xue R; Wu H; Shao D; Li J; Zhou Y; Li S; Yang R; Pedersen OB; Yu Z; Ehrlich SD; Ren F
Gut; 2020 Dec; 69(12):2131-2142. PubMed ID: 32241904
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis of fecal microbiome and metabolome during renal fibrotic progression in a unilateral ureteral obstruction animal model.
Hu X; Xie Y; Xiao Y; Zeng W; Gong Z; Du J
Eur J Pharmacol; 2020 Nov; 886():173555. PubMed ID: 32937112
[TBL] [Abstract][Full Text] [Related]
4. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD.
Barba C; Soulage CO; Caggiano G; Glorieux G; Fouque D; Koppe L
Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255454
[TBL] [Abstract][Full Text] [Related]
5. Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.
Behr C; Slopianka M; Haake V; Strauss V; Sperber S; Kamp H; Walk T; Beekmann K; Rietjens IMCM; van Ravenzwaay B
Toxicol Appl Pharmacol; 2019 Jan; 363():79-87. PubMed ID: 30502395
[TBL] [Abstract][Full Text] [Related]
6. Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease.
Zhang P; Wang X; Li S; Cao X; Zou J; Fang Y; Shi Y; Xiang F; Shen B; Li Y; Fang B; Zhang Y; Guo R; Lv Q; Zhang L; Lu Y; Wang Y; Yu J; Xie Y; Wang R; Chen X; Yu J; Zhang Z; He J; Zhan J; Lv W; Nie Y; Cai J; Xu X; Hu J; Zhang Q; Gao T; Jiang X; Tan X; Xue N; Wang Y; Ren Y; Wang L; Zhang H; Ning Y; Chen J; Zhang L; Jin S; Ren F; Ehrlich SD; Zhao L; Ding X
Genome Biol; 2023 Oct; 24(1):226. PubMed ID: 37828586
[TBL] [Abstract][Full Text] [Related]
7. Compositional and Functional Adaptations of Intestinal Microbiota and Related Metabolites in CKD Patients Receiving Dietary Protein Restriction.
Wu IW; Lee CC; Hsu HJ; Sun CY; Chen YC; Yang KJ; Yang CW; Chung WH; Lai HC; Chang LC; Su SC
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32932711
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive and semi-quantitative analysis of carboxyl-containing metabolites related to gut microbiota on chronic kidney disease using 2-picolylamine isotopic labeling LC-MS/MS.
Kanemitsu Y; Mishima E; Maekawa M; Matsumoto Y; Saigusa D; Yamaguchi H; Ogura J; Tsukamoto H; Tomioka Y; Abe T; Mano N
Sci Rep; 2019 Dec; 9(1):19075. PubMed ID: 31836785
[TBL] [Abstract][Full Text] [Related]
9.
Hanifi GR; Samadi Kafil H; Tayebi Khosroshahi H; Shapouri R; Asgharzadeh M
Arch Razi Inst; 2021; 76(3):521-528. PubMed ID: 34824745
[No Abstract] [Full Text] [Related]
10. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.
Mishima E; Fukuda S; Shima H; Hirayama A; Akiyama Y; Takeuchi Y; Fukuda NN; Suzuki T; Suzuki C; Yuri A; Kikuchi K; Tomioka Y; Ito S; Soga T; Abe T
J Am Soc Nephrol; 2015 Aug; 26(8):1787-94. PubMed ID: 25525179
[TBL] [Abstract][Full Text] [Related]
12. Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD.
Kortman GAM; Reijnders D; Swinkels DW
Hemodial Int; 2017 Jun; 21 Suppl 1():S28-S36. PubMed ID: 28328083
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective effects of paramylon, a β-1,3-D-Glucan isolated from Euglena gracilis Z in a rodent model of chronic kidney disease.
Nagayama Y; Isoo N; Nakashima A; Suzuki K; Yamano M; Nariyama T; Yagame M; Matsui K
PLoS One; 2020; 15(8):e0237086. PubMed ID: 32764782
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota in chronic kidney disease.
Cigarran Guldris S; González Parra E; Cases Amenós A
Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
[TBL] [Abstract][Full Text] [Related]
16. Specific gut microbiome and metabolome changes in patients with continuous ambulatory peritoneal dialysis and comparison between patients with different dialysis vintages.
Li J; Xing H; Lin W; Yu H; Yang B; Jiang C; Zhang J; Wu R; Ding F; Pei M; Yang H
Front Med (Lausanne); 2023; 10():1302352. PubMed ID: 38249961
[TBL] [Abstract][Full Text] [Related]
17. Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity.
Wang H; Ainiwaer A; Song Y; Qin L; Peng A; Bao H; Qin H
Microbiome; 2023 Jan; 11(1):3. PubMed ID: 36624472
[TBL] [Abstract][Full Text] [Related]
18. Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective.
Lohia S; Vlahou A; Zoidakis J
Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324673
[TBL] [Abstract][Full Text] [Related]
19. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.
Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH
Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125
[TBL] [Abstract][Full Text] [Related]
20. Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles.
Erawijantari PP; Mizutani S; Shiroma H; Shiba S; Nakajima T; Sakamoto T; Saito Y; Fukuda S; Yachida S; Yamada T
Gut; 2020 Aug; 69(8):1404-1415. PubMed ID: 31953253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
